COVID Rounds: EU Episode 4

CME

COVID-19 in EU: Review of Treatment Options for Severe COVID-19 for People Who Are Immunocompromised

European Learners: 0.50 hours EBAC® effective education time

Released: March 11, 2025

Expiration: March 10, 2026

Activity

Progress
1 2
Course Completed

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss treatment strategies for people who are immunocompromised with COVID-19 in the hospital setting, including:

  • Antiviral therapy with remdesivir
  • Dexamethasone for patients with hematologic malignancies
  • Considerations regarding other immunomodulators such as JAK inhibitors or IL-6 inhibitors
  • A detailed patient case to illustrate key takeaways